Free Neurology CME 2017‑2018 | CMEList.com

 


The Best of Stroke Forum 2016  Free Stroke CME
Posted by...Bernard Sklar, MD. 
Free CME Credit Hours...0.5.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Emergency medicine physicians, neurologists, emergency medicine residents, nurses, physician assistants, nurse practitioners, and other health care professionals involved in the treatment of patients with AIS.
Educational material last updated...November 10, 2016.
CME Credit Expires...November 9, 2017.
Financial Support...Genentech, Inc.
The Best of Stroke Forum 2016 consists of two brief lectures:
• Eligibility for IV Thrombolysis: A Review of Inclusion and Exclusion Criteria
• Stroke Therapy: Examining New Evidence
After competing The Best of Stroke Forum 2016, you should be better able to:
• Apply evidence-based criteria to the selection of candidates for thrombolytic therapy in AIS.
• Evaluate FDA labeling, current data, and clinical practice guidelines on the use of tissue plasminogen activator in the extended 3-hour to 4.5-hour post-onset window.
• Assess recent studies and guidelines on endovascular procedures for AIS.
• Determine the criteria for the concomitant or preferential use of tissue plasminogen activator in patients with AIS who are being considered for endovascular procedures.
• Incorporate shared decision making with patients and their families to improve education and assist in reducing delays in treatment and complications.

Updates in Alzheimer's Disease: An Expert Interview Series
Posted by...Bernard Sklar, MD.
Free CME Credit Hours...0.5.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Primary care providers, neurologists, gerontologists, radiologists, nuclear medicine physicians, and other health care professionals involved in the treatment of patients with Alzheimer's disease.
Educational material last updated...October 11th, 2016.
CME Credit Expires...October 10th, 2017.
Financial Support...Lilly.
Updates in Alzheimer's Disease consists of two brief lectures:
• Emerging Therapies for the Treatment of Alzheimer's Disease
• Alzheimer's Disease: Updates on Diagnostics and Early-stage Management
After competing Updates in Alzheimer's Disease, you should be better able to:
• Evaluate evidence-based strategies for the early diagnosis of Alzheimer's disease.
• Review the latest data of the pathophysiology and management strategies for pre-symptomatic and mild Alzheimer's disease.
• Evaluate the latest safety and efficacy data for new and emerging agents for the treatment of Alzheimer's disease.

Lennox-Gastaut Syndrome: Improving Patient Outcomes Through Better Diagnosis and Management Free Neurology CME 
Live online October 7, 2016, and available on demand through October 13, 2017.
Posted by...Bernard Sklar, MD.
Free Neurology CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine and Montefiore Medical Center.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for US-based epileptologists, community neurologists (pediatric and adult), primary care physicians, pediatricians, medical directors from long-term care facilities, and other clinicians involved in the care of patients with Lennox-Gastaut Syndrome.
Educational material updated... October 7, 2016.
Expiration of CME credit... October 13, 2017.
Financial Support...Lundbeck.
Topics covered in Lennox-Gastaut Syndrome include: 
• Barriers to effective diagnosis and management of LGS (Lennox-Gastaut Syndrome) in pediatric and adult settings
• What is the "triad" and evolving seizure patterns of LGS as patients age
• Diagnostic approaches to differentiate LGS from other forms of epileptic encephalopathies
• Management strategies as patients age, seizure characteristics change, and behavioral or other issues arise
• Multidisciplinary approach to lifelong management of LGS and key elements for a smooth transition from pediatric to adult services
At the conclusion of Lennox-Gastaut Syndrome, you will be better able to:
• Identify characteristics associated with LGS from other forms of epilepsy, and evolving seizure profiles over the course of a patient's life
• Devise effective and tolerable pharmacotherapeutic treatment options for LGS as appropriate to pediatric and adult patients
• Evaluate the relative efficacy and safety of alternative therapies and nonpharmacologic strategies for the management of LGS
• Describe the key elements of a care plan that will ensure smooth transition from pediatric care to adult care in patients with LGS

Cases, Challenges, And Care of Pseudobulbar Affect in Neurological Diseases
Live online September 13, 2016, and available on demand through September 13, 2017.Free Neurology CME
Posted by...Bernard Sklar, MD.
Free Neurology CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for US-based neurologists, psychiatrists, geriatricians, primary care clinicians (internal, general and family medicine), and health care providers involved in the care of patients with neurological diseases who may be suffering from pseudobulbar affect (PBA).
Educational material updated... September 13, 2016.
Expiration of CME credit... September 13, 2017.
Financial Support...Avanir.
Pseudobulbar Affect in Neurological Diseases consists of a single lecture with discussion:
• Cases, Challenges, And Care of Pseudobulbar Affect in Neurological Diseases
At the conclusion of Pseudobulbar Affect in Neurological Diseases, you will be able to:
• Summarize the impact of pseudobulbar affect (PBA) in patients with neurologic disease
• Evaluate and diagnose PBA in patients with neurologic disease
• Implement a management plan for patients with PBA with provisions for follow up and ongoing assessment of symptoms

Updates in Migraine Headaches: Best practices and Emerging Therapies in Treatment and Prevention 
Posted by...Bernard Sklar, MD. Free Neurology CME Free Pain Management CME
Free Neurology and Pain Management CME Credit hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...Healthcare professionals who are: primary care physicians, neurologists, headache specialists, nurse practitioners, physician assistants, nurses, OB-GYN specialists, pharmacists, and those who otherwise commonly care for or clinically encounter patients who may experience migraine headache.
Educational material updated...July 20, 2016.
Expiration of CME credit...July 20, 2018.
Financial Support...AMGEN and Promius.
After viewing Updates in Migraine Headaches, you will be able to:
• Describe the prevalence of migraine symptoms and the impact that these symptoms have on efficacy of anti-migraine therapy and functional status
• Describe the sometimes variable manifestations (e.g., incidence and clinical presentation) of migraine headaches, depending on age and sex
• Recall emerging therapies for the treatment and prevention of chronic migraine headache and anticipate their place in therapy
• Support team-based learning and communication between all clinicians involved with the care of patients suffering with migraines
• Given a series of patient cases, diagnosis and treat migraine headaches by employing current treatment guidelines, using evidence-based therapy algorithms, and providing individualized approaches to care

Clinical Insights on Multiple Sclerosis Management from AAN 2016   
Live online April 26, 2016, and available on demand through April 26, 2017.
Posted by...Bernard Sklar, MD.
Free Multiple Sclerosis CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This activity is intended for US-based neurologists, neurology nurses, nurse practitioners and physician assistants, as well as primary care clinicians who manage patients with multiple sclerosis. 
Educational material updated...April 26, 2016.
Expiration of CME credit...April 26, 2017.
Financial Support...Genentech.
Clinical Insights on Multiple Sclerosis Management consists of a single lecture with discussion:
• Clinical Insights on Multiple Sclerosis Management from AAN 2016 with  Fred Lublin, MD of The Mount Sinai Hospital and  Patricia K. Coyle, MD of Stony Brook University.
Topics covered by Clinical Insights on Multiple Sclerosis Management include:
• Recent clinical trial data on the safety and efficacy of current and emerging disease-modifying therapies for MS 
• Individualized, evidence-based treatment plans for patients with MS based on up-to-date clinical evidence 
• Expert-recommended strategies for selecting initial therapies, deciding when and how to advance therapy, and managing actively or aggressively progressing disease
After viewing Clinical Insights on Multiple Sclerosis Management you will be better able to:
• Evaluate recent clinical trial data on the safety and efficacy of current and emerging disease-modifying therapies for MS, and apply to appropriate treatment selection for patients with MS 
• Develop individualized, evidence-based treatment plans for patients with MS based on up-to-date clinical evidence as well as expert-recommended strategies for selecting initial therapies, deciding when and how to advance therapy, and managing actively or aggressively progressing disease

Alzheimer Disease (AD) and Its Complications: Best Practices, Emerging Therapies, and Barriers to Care Alzheimer's Disease CME 
Posted by...Bernard Sklar, MD.
Alzheimer's Disease CME Credit hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture.
Target Audiences...Healthcare professionals specializing in: neurology, gerontology, internal medicine, palliative care, or those who otherwise commonly care for patients with AD or who frequently encounter them or their caregivers in practice.
Educational material updated...December 21, 2015.
Expiration of CME credit...December 21, 2017.
Financial Support...AVANIR.
Topics covered in Alzheimer Disease (AD) and Its Complications include:
Epidemiology of and risk factors for Alzheimer Disease (AD), Symptomatology and diagnosis of AD, Treatment in patients with AD, Complications and barriers to optimal care in patients with AD and many more.
After completing Alzheimer Disease (AD) and Its Complications, you will be able to:
• Describe what is presently known about the pathophysiology of AD and the challenges associated with diagnosis and treatment of AD.
• Evaluate a treatment plan for a specific patient based on degree of AD to optimize safety and efficacy, suggesting modifications for improvement.
• Identify the present treatment options currently available for management of AD and apply them to patient cases using evidence-based medicine.
• Describe emerging drug therapies in the treatment of AD.
• Describe barriers to care and suggest therapies for treating cognitive and behavioral complications secondary to AD. 
In order to get credit from ScientiaCME, you must first establish a username and password.

Pediatric Patients with High-Risk Neuroblastoma: Perspectives on Diagnosis and Management Free Cancer CME
Live online June 9, 2016, and available on demand through September 20, 2017.
Posted by...Bernard Sklar, MD.
Free Cancer CME Credit hours...1.0.
CME Credits Awarded by....Postgraduate Institute for Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for oncologists, surgeons, nurses, pharmacists, physician assistants, and health care providers who care for or have an interest in pediatric patients with high-risk neuroblastoma.
Educational material updated...June 9, 2016.
Expiration of CME credit...September 20, 2017.
Financial Support...United Therapeutics.
Topics covered by Pediatric Patients with High-Risk Neuroblastoma include:
• Treatment options for the management of high-risk pediatric neuroblastoma, including chemotherapy, surgery, radiotherapy, and immunological treatments 
• Managing immediate and late effects of therapy for pediatric neuroblastoma 
• Patient-related needs associated with agents used for high-risk pediatric neuroblastoma 
• Current evidence-based practice and research topics regarding the care of pediatric patients with high-risk neuroblastoma
• Collaborative comprehensive care for patients with high-risk pediatric neuroblastoma
• Current evidence-based practice and research topics regarding the care of pediatric patients with high-risk neuroblastoma 
At the conclusion of Pediatric Patients with High-Risk Neuroblastoma, you will be able to:
• Review treatment options for the management of high-risk pediatric neuroblastoma, including chemotherapy, surgery, radiotherapy, and immunological treatments
• Manage immediate and late effects of therapy for pediatric neuroblastoma
• Describe patient-related needs associated with agents used for high-risk pediatric neuroblastoma
• Evaluate current evidence-based practice and research topics regarding the care of pediatric patients with high-risk neuroblastoma
• Provide collaborative comprehensive care for patients with high-risk pediatric neuroblastoma

ScientiaCME Neuropsychiatry-Neurology Free Neurology CME ScientiaCME Neurology  
Posted by...Bernard Sklar, MD.
Neurology Credit hours...3.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...NEUROLOGY.
CME Credit Expires...Two years after release.
Financial Support...Various commercial supporters. 

ScientiaCME Treatment strategies in Gaucher disease Free Gaucher Disease CME
CME Credit Hours...1.25.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...Cardiology, genetic disorders, hematology, oncology, orthopedics, gastroenterology, neurology and pediatrics.
Educational material updated....February 12, 2017.
Expiration of CME credit...February 12, 2019.
Financial Support...Shire.
At the conclusion of By the end of Treatment strategies in Gaucher disease, you will be able to:
• Describe the importance of appropriate GD (Gaucher Disease) diagnosis and treatment (use • for bullets)
• Determine the likelihood of GD using with established diagnosis methods, given a patient case
• Describe present therapies for the treatment of GD and the literature supporting their use
• Design a medical plan to treat a patient with GD, taking into account presently available therapies





-->